Advances in understanding iron metabolism and its crosstalk with erythropoiesis

British Journal of Haematology

Volumn 182, Issue 4, 2018, Pages 481-494

  Camaschella, Clara ^a   Pagani, Alessia ^a  

^a SAN RAFFAELE HOSPITAL   (Italy)

Author keywords

erythropoiesis; erythropoietin; hepcidin; iron; thalassaemia

Indexed keywords

BIOLOGICAL MARKER; CARRIER PROTEINS AND BINDING PROTEINS; HEPCIDIN; IRON TRANSPORTER; UNCLASSIFIED DRUG; ZINC TRANSPORTER; HAMP PROTEIN, HUMAN; IRON;

ANTIOXIDANT RESPONSIVE ELEMENT; ERYTHROPOIESIS; GENE EXPRESSION REGULATION; HUMAN; INFLAMMATION; IRON HOMEOSTASIS; IRON METABOLISM; IRON OVERLOAD; IRON TRANSPORT; MEDICAL RESEARCH; MOLECULAR INTERACTION; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN SYNTHESIS INHIBITION; PROTEIN TARGETING; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; METABOLISM; MOUSE; PATHOLOGY;

ANIMALS; ERYTHROPOIESIS; HEPCIDINS; HUMANS; IRON; IRON OVERLOAD; MICE; SIGNAL TRANSDUCTION;

EID: 85051421096     PISSN: 00071048     EISSN: 13652141     Source Type: Journal    
DOI: 10.1111/bjh.15403     Document Type: Review

References (99)

1. Altamura, S., Kessler, R., Grone, H.J., Gretz, N., Hentze, M.W., Galy, B. & Muckenthaler, M.U. (2014) Resistance of ferroportin to hepcidin binding causes exocrine pancreatic failure and fatal iron overload. Cell Metabolism, 20, 359–367.
2. Anderson, S.A., Nizzi, C.P., Chang, Y.I., Deck, K.M., Schmidt, P.J., Galy, B., Damnernsawad, A., Broman, A.T., Kendziorski, C., Hentze, M.W., Fleming, M.D., Zhang, J. & Eisenstein, R.S. (2013) The IRP1-HIF-2alpha axis coordinates iron and oxygen sensing with erythropoiesis and iron absorption. Cell Metabolism, 17, 282–290.
3. Aschemeyer, S., Qiao, B., Stefanova, D., Valore, E.V., Sek, A.C., Ruwe, T.A., Vieth, K.R., Jung, G., Casu, C., Rivella, S., Jormakka, M., Mackenzie, B., Ganz, T. & Nemeth, E. (2018) Structure-function analysis of ferroportin defines the binding site and an alternative mechanism of action of hepcidin. Blood, 131, 899–910.
4. Babitt, J.L., Huang, F.W., Wrighting, D.M., Xia, Y., Sidis, Y., Samad, T.A., Campagna, J.A., Chung, R.T., Schneyer, A.L., Woolf, C.J., Andrews, N.C. & Lin, H.Y. (2006) Bone morphogenetic protein signaling by hemojuvelin regulates hepcidin expression. Nature Genetics, 38, 531–539.
5. Barrientos, T., Laothamatas, I., Koves, T.R., Soderblom, E.J., Bryan, M., Moseley, M.A., Muoio, D.M. & Andrews, N.C. (2015) Metabolic catastrophe in mice lacking transferrin receptor in muscle. EBioMedicine, 2, 1705–1717.
6. Bayeva, M., Khechaduri, A., Puig, S., Chang, H.C., Patial, S., Blackshear, P.J. & Ardehali, H. (2012) mTOR regulates cellular iron homeostasis through tristetraprolin. Cell Metabolism, 16, 645–657.
7. Bellelli, R., Federico, G., Matte, A., Colecchia, D., Iolascon, A., Chiariello, M., Santoro, M., De Franceschi, L. & Carlomagno, F. (2016) NCOA4 deficiency impairs systemic iron homeostasis. Cell Reports, 14, 411–421.
8. Bregman, D.B., Morris, D., Koch, T.A., He, A. & Goodnough, L.T. (2013) Hepcidin levels predict nonresponsiveness to oral iron therapy in patients with iron deficiency anemia. American Journal of Hematology, 88, 97–101.
9. Camaschella, C. (2015) Iron-deficiency anemia. The New England Journal of Medicine, 372, 1832–1843.
10. Camaschella, C. (2017) New insights into iron deficiency and iron deficiency anemia. Blood Reviews, 31, 225–233.
11. Camaschella, C. & Nai, A. (2016) Ineffective erythropoiesis and regulation of iron status in iron loading anaemias. British Journal of Haematology, 172, 512–523.
12. Camaschella, C., Roetto, A., Cali, A., De Gobbi, M., Garozzo, G., Carella, M., Majorano, N., Totaro, A. & Gasparini, P. (2000) The gene TFR2 is mutated in a new type of haemochromatosis mapping to 7q22. Nature Genetics, 25, 14–15.
13. Canali, S., Core, A.B., Zumbrennen-Bullough, K.B., Merkulova, M., Wang, C.Y., Schneyer, A.L., Pietrangelo, A. & Babitt, J.L. (2016) Activin B Induces Noncanonical SMAD1/5/8 Signaling via BMP Type I receptors in hepatocytes: evidence for a role in hepcidin induction by inflammation in male mice. Endocrinology, 157, 1146–1162.
14. Canali, S., Wang, C.Y., Zumbrennen-Bullough, K.B., Bayer, A. & Babitt, J.L. (2017a) Bone morphogenetic protein 2 controls iron homeostasis in mice independent of Bmp6. American Journal of Hematology, 92, 1204–1213.
15. Canali, S., Zumbrennen-Bullough, K.B., Core, A.B., Wang, C.Y., Nairz, M., Bouley, R., Swirski, F.K. & Babitt, J.L. (2017b) Endothelial cells produce bone morphogenetic protein 6 required for iron homeostasis in mice. Blood, 129, 405–414.
16. Casu, C., Oikonomidou, P.R., Chen, H., Nandi, V., Ginzburg, Y., Prasad, P., Fleming, R.E., Shah, Y.M., Valore, E.V., Nemeth, E., Ganz, T., MacDonald, B. & Rivella, S. (2016) Minihepcidin peptides as disease modifiers in mice affected by beta-thalassemia and polycythemia vera. Blood, 128, 265–276.
17. Chen, A.C., Donovan, A., Ned-Sykes, R. & Andrews, N.C. (2015) Noncanonical role of transferrin receptor 1 is essential for intestinal homeostasis. Proceedings of the National Academy of Sciences of the United States of America, 112, 11714–11719.
18. Cohen, N., Breker, M., Bakunts, A., Pesek, K., Chas, A., Argemi, J., Orsi, A., Gal, L., Chuartzman, S., Wigelman, Y., Jonas, F., Walter, P., Ernst, R., Aragon, T., van Anken, E. & Schuldiner, M. (2017) Iron affects Ire1 clustering propensity and the amplitude of endoplasmic reticulum stress signaling. Journal of Cell Science, 130, 3222–3233.
19. Colucci, S., Pagani, A., Pettinato, M., Artuso, I., Nai, A., Camaschella, C. & Silvestri, L. (2017) The immunophilin FKBP12 inhibits hepcidin expression by binding the BMP type I receptor ALK2 in hepatocytes. Blood, 130, 2111–2120.
20. Crielaard, B.J., Lammers, T. & Rivella, S. (2017) Targeting iron metabolism in drug discovery and delivery. Nature reviews. Drug discovery, 16, 400–423.
21. De Falco, L., Silvestri, L., Kannengiesser, C., Moran, E., Oudin, C., Rausa, M., Bruno, M., Aranda, J., Argiles, B., Yenicesu, I., Falcon-Rodriguez, M., Yilmaz-Keskin, E., Kocak, U., Beaumont, C., Camaschella, C., Iolascon, A., Grandchamp, B. & Sanchez, M. (2014) Functional and clinical impact of novel TMPRSS6 variants in iron-refractory iron-deficiency anemia patients and genotype-phenotype studies. Human Mutation, 35, 1321–1329.
22. Dowdle, W.E., Nyfeler, B., Nagel, J., Elling, R.A., Liu, S., Triantafellow, E., Menon, S., Wang, Z., Honda, A., Pardee, G., Cantwell, J., Luu, C., Cornella-Taracido, I., Harrington, E., Fekkes, P., Lei, H., Fang, Q., Digan, M.E., Burdick, D., Powers, A.F., Helliwell, S.B., D'Aquin, S., Bastien, J., Wang, H., Wiederschain, D., Kuerth, J., Bergman, P., Schwalb, D., Thomas, J., Ugwonali, S., Harbinski, F., Tallarico, J., Wilson, C.J., Myer, V.E., Porter, J.A., Bussiere, D.E., Finan, P.M., Labow, M.A., Mao, X., Hamann, L.G., Manning, B.D., Valdez, R.A., Nicholson, T., Schirle, M., Knapp, M.S., Keaney, E.P. & Murphy, L.O. (2014) Selective VPS34 inhibitor blocks autophagy and uncovers a role for NCOA4 in ferritin degradation and iron homeostasis in vivo. Nature Cell Biology, 16, 1069–1079.
23. Drakesmith, H., Nemeth, E. & Ganz, T. (2015) Ironing out Ferroportin. Cell Metabolism, 22, 777–787.
24. Du, X., She, E., Gelbart, T., Truksa, J., Lee, P., Xia, Y., Khovananth, K., Mudd, S., Mann, N., Moresco, E.M., Beutler, E. & Beutler, B. (2008) The serine protease TMPRSS6 is required to sense iron deficiency. Science, 320, 1088–1092.
25. Dussiot, M., Maciel, T.T., Fricot, A., Chartier, C., Negre, O., Veiga, J., Grapton, D., Paubelle, E., Payen, E., Beuzard, Y., Leboulch, P., Ribeil, J.A., Arlet, J.B., Cote, F., Courtois, G., Ginzburg, Y.Z., Daniel, T.O., Chopra, R., Sung, V., Hermine, O. & Moura, I.C. (2014) An activin receptor IIA ligand trap corrects ineffective erythropoiesis in beta-thalassemia. Nature Medicine, 20, 398–407.
26. Enns, C.A., Ahmed, R., Wang, J., Ueno, A., Worthen, C., Tsukamoto, H. & Zhang, A.S. (2013) Increased iron loading induces Bmp6 expression in the non-parenchymal cells of the liver independent of the BMP-signaling pathway. PLoS ONE, 8, e60534.
27. Fernandes, J.L., Loggetto, S.R., Verissimo, M.P., Fertrin, K.Y., Baldanzi, G.R., Fioravante, L.A., Tan, D.M., Higa, T., Mashima, D.A., Piga, A., Coelho, O.R., Costa, F.F. & Saad, S.T. (2016) A randomized trial of amlodipine in addition to standard chelation therapy in patients with thalassemia major. Blood, 128, 1555–1561.
28. Finberg, K.E., Heeney, M.M., Campagna, D.R., Aydinok, Y., Pearson, H.A., Hartman, K.R., Mayo, M.M., Samuel, S.M., Strouse, J.J., Markianos, K., Andrews, N.C. & Fleming, M.D. (2008) Mutations in TMPRSS6 cause iron-refractory iron deficiency anemia (IRIDA). Nature Genetics, 40, 569–571.
29. Finberg, K.E., Whittlesey, R.L. & Andrews, N.C. (2011) Tmprss6 is a genetic modifier of the Hfe-hemochromatosis phenotype in mice. Blood, 117, 4590–4599.
30. Finch, C. (1994) Regulators of iron balance in humans. Blood, 84, 1697–1702.
31. Fleming, M.D., Romano, M.A., Su, M.A., Garrick, L.M., Garrick, M.D. & Andrews, N.C. (1998) Nramp2 is mutated in the anemic Belgrade (b) rat: evidence of a role for Nramp2 in endosomal iron transport. Proceedings of the National Academy of Sciences of the United States of America, 95, 1148–1153.
32. Forejtnikova, H., Vieillevoye, M., Zermati, Y., Lambert, M., Pellegrino, R.M., Guihard, S., Gaudry, M., Camaschella, C., Lacombe, C., Roetto, A., Mayeux, P. & Verdier, F. (2010) Transferrin receptor 2 is a component of the erythropoietin receptor complex and is required for efficient erythropoiesis. Blood, 116, 5357–5367.
33. Galy, B., Ferring-Appel, D., Becker, C., Gretz, N., Grone, H.J., Schumann, K. & Hentze, M.W. (2013) Iron regulatory proteins control a mucosal block to intestinal iron absorption. Cell Reports, 3, 844–857.
34. Ganz, T., Jung, G., Naeim, A., Ginzburg, Y., Pakbaz, Z., Walter, P.B., Kautz, L. & Nemeth, E. (2017) Immunoassay for human serum erythroferrone. Blood, 130, 1243–1246.
35. Ghosh, M.C., Zhang, D.L., Jeong, S.Y., Kovtunovych, G., Ollivierre-Wilson, H., Noguchi, A., Tu, T., Senecal, T., Robinson, G., Crooks, D.R., Tong, W.H., Ramaswamy, K., Singh, A., Graham, B.B., Tuder, R.M., Yu, Z.X., Eckhaus, M., Lee, J., Springer, D.A. & Rouault, T.A. (2013) Deletion of iron regulatory protein 1 causes polycythemia and pulmonary hypertension in mice through translational derepression of HIF2alpha. Cell Metabolism, 17, 271–281.
36. Girelli, D., Trombini, P., Busti, F., Campostrini, N., Sandri, M., Pelucchi, S., Westerman, M., Ganz, T., Nemeth, E., Piperno, A. & Camaschella, C. (2011) A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis. Haematologica, 96, 500–506.
37. Girelli, D., Nemeth, E. & Swinkels, D.W. (2016) Hepcidin in the diagnosis of iron disorders. Blood, 127, 2809–2813.
38. Grillo, A.S., SantaMaria, A.M., Kafina, M.D., Cioffi, A.G., Huston, N.C., Han, M., Seo, Y.A., Yien, Y.Y., Nardone, C., Menon, A.V., Fan, J., Svoboda, D.C., Anderson, J.B., Hong, J.D., Nicolau, B.G., Subedi, K., Gewirth, A.A., Wessling-Resnick, M., Kim, J., Paw, B.H. & Burke, M.D. (2017) Restored iron transport by a small molecule promotes absorption and hemoglobinization in animals. Science, 356, 608–616.
39. Guo, S., Casu, C., Gardenghi, S., Booten, S., Aghajan, M., Peralta, R., Watt, A., Freier, S., Monia, B.P. & Rivella, S. (2013) Reducing TMPRSS6 ameliorates hemochromatosis and beta-thalassemia in mice. The Journal of Clinical Investigation, 123, 1531–1541.
40. Haddad, S., Wang, Y., Galy, B., Korf-Klingebiel, M., Hirsch, V., Baru, A.M., Rostami, F., Reboll, M.R., Heineke, J., Flogel, U., Groos, S., Renner, A., Toischer, K., Zimmermann, F., Engeli, S., Jordan, J., Bauersachs, J., Hentze, M.W., Wollert, K.C. & Kempf, T. (2017) Iron-regulatory proteins secure iron availability in cardiomyocytes to prevent heart failure. European Heart Journal, 38, 362–372.
41. Hamdi, A., Roshan, T.M., Kahawita, T.M., Mason, A.B., Sheftel, A.D. & Ponka, P. (2016) Erythroid cell mitochondria receive endosomal iron by a “kiss-and-run” mechanism. Biochimica et Biophysica Acta, 1863, 2859–2867.
42. Healey, E.G., Bishop, B., Elegheert, J., Bell, C.H., Padilla-Parra, S. & Siebold, C. (2015) Repulsive guidance molecule is a structural bridge between neogenin and bone morphogenetic protein. Nature Structural & Molecular Biology, 22, 458–465.
43. Hentze, M.W., Muckenthaler, M.U., Galy, B. & Camaschella, C. (2010) Two to tango: regulation of Mammalian iron metabolism. Cell, 142, 24–38.
44. Iolascon, A., d'Apolito, M., Servedio, V., Cimmino, F., Piga, A. & Camaschella, C. (2006) Microcytic anemia and hepatic iron overload in a child with compound heterozygous mutations in DMT1 (SCL11A2). Blood, 107, 349–354.
45. Jabara, H.H., Boyden, S.E., Chou, J., Ramesh, N., Massaad, M.J., Benson, H., Bainter, W., Fraulino, D., Rahimov, F., Sieff, C., Liu, Z.J., Alshemmari, S.H., Al-Ramadi, B.K., Al-Dhekri, H., Arnaout, R., Abu-Shukair, M., Vatsayan, A., Silver, E., Ahuja, S., Davies, E.G., Sola-Visner, M., Ohsumi, T.K., Andrews, N.C., Notarangelo, L.D., Fleming, M.D., Al-Herz, W., Kunkel, L.M. & Geha, R.S. (2016) A missense mutation in TFRC, encoding transferrin receptor 1, causes combined immunodeficiency. Nature Genetics, 48, 74–78.
46. Jenkitkasemwong, S., Wang, C.Y., Coffey, R., Zhang, W., Chan, A., Biel, T., Kim, J.S., Hojyo, S., Fukada, T. & Knutson, M.D. (2015) SLC39A14 is required for the development of hepatocellular iron overload in murine models of hereditary hemochromatosis. Cell Metabolism, 22, 138–150.
47. Kautz, L., Jung, G., Valore, E.V., Rivella, S., Nemeth, E. & Ganz, T. (2014) Identification of erythroferrone as an erythroid regulator of iron metabolism. Nature Genetics, 46, 678–684.
48. Kautz, L., Jung, G., Du, X., Gabayan, V., Chapman, J., Nasoff, M., Nemeth, E. & Ganz, T. (2015) Erythroferrone contributes to hepcidin suppression and iron overload in a mouse model of beta-thalassemia. Blood, 126, 2031–2037.
49. Khalil, S., Delehanty, L., Grado, S., Holy, M., White, Z. 3rd, Freeman, K., Kurita, R., Nakamura, Y., Bullock, G. & Goldfarb, A. (2018) Iron modulation of erythropoiesis is associated with Scribble-mediated control of the erythropoietin receptor. The Journal of Experimental Medicine, 215, 661–679.
50. Koch, P.S., Olsavszky, V., Ulbrich, F., Sticht, C., Demory, A., Leibing, T., Henzler, T., Meyer, M., Zierow, J., Schneider, S., Breitkopf-Heinlein, K., Gaitantzi, H., Spencer-Dene, B., Arnold, B., Klapproth, K., Schledzewski, K., Goerdt, S. & Geraud, C. (2017) Angiocrine Bmp2 signaling in murine liver controls normal iron homeostasis. Blood, 129, 415–419.
51. Lakhal-Littleton, S., Wolna, M., Chung, Y.J., Christian, H.C., Heather, L.C., Brescia, M., Ball, V., Diaz, R., Santos, A., Biggs, D., Clarke, K., Davies, B. & Robbins, P.A. (2016). An essential cell-autonomous role for hepcidin in cardiac iron homeostasis. eLife 5, pii. e19804.
52. Latour, C., Kautz, L., Besson-Fournier, C., Island, M.L., Canonne-Hergaux, F., Loreal, O., Ganz, T., Coppin, H. & Roth, M.P. (2014) Testosterone perturbs systemic iron balance through activation of epidermal growth factor receptor signaling in the liver and repression of hepcidin. Hepatology, 59, 683–694.
53. Latour, C., Besson-Fournier, C., Meynard, D., Silvestri, L., Gourbeyre, O., Aguilar-Martinez, P., Schmidt, P.J., Fleming, M.D., Roth, M.P. & Coppin, H. (2016) Differing impact of the deletion of hemochromatosis-associated molecules HFE and transferrin receptor-2 on the iron phenotype of mice lacking bone morphogenetic protein 6 or hemojuvelin. Hepatology, 63, 126–137.
54. Latour, C., Besson-Fournier, C., Gourbeyre, O., Meynard, D., Roth, M.P. & Coppin, H. (2017) Deletion of BMP6 worsens the phenotype of HJV-deficient mice and attenuates hepcidin levels reached after LPS challenge. Blood, 130, 2339–2343.
55. Lee, T., Clavel, T., Smirnov, K., Schmidt, A., Lagkouvardos, I., Walker, A., Lucio, M., Michalke, B., Schmitt-Kopplin, P., Fedorak, R. & Haller, D. (2017) Oral versus intravenous iron replacement therapy distinctly alters the gut microbiota and metabolome in patients with IBD. Gut, 66, 863–871.
56. Levy, J.E., Jin, O., Fujiwara, Y., Kuo, F. & Andrews, N.C. (1999) Transferrin receptor is necessary for development of erythrocytes and the nervous system. Nature Genetics, 21, 396–399.
57. Lewis, G.D., Malhotra, R., Hernandez, A.F., McNulty, S.E., Smith, A., Felker, G.M., Tang, W.H.W., LaRue, S.J., Redfield, M.M., Semigran, M.J., Givertz, M.M., Van Buren, P., Whellan, D., Anstrom, K.J., Shah, M.R., Desvigne-Nickens, P., Butler, J. & Braunwald, E. (2017) Effect of oral iron repletion on exercise capacity in patients with heart failure with reduced ejection fraction and iron deficiency: the IRONOUT HF randomized clinical trial. JAMA, 317, 1958–1966.
58. Li, H., Choesang, T., Bao, W., Chen, H., Feola, M., Garcia-Santos, D., Li, J., Sun, S., Follenzi, A., Pham, P., Liu, J., Zhang, J., Ponka, P., An, X., Mohandas, N., Fleming, R.E., Rivella, S., Li, G. & Ginzburg, Y.Z. (2017) Decreasing TfR1 expression reverses anemia and hepcidin suppression in beta-thalassemic mice. Blood, 129, 1514–1526.
59. Lim, P.J., Duarte, T., Pasricha, S., Armitage, A., Santos, A., Santos-Goncalves, A., Schwessinger, R., Hughes, J., Soilleux, E., Wang, C., Babitt, J., Porto, G. & Drakesmith, H. (2018). Nrf2 links cellular and systemic iron homeostasis via BMP6 and hepcidin, and regulates hemochromatosis. In: European Iron Club-EIC meeting 2018, Zurich Abstract book, page 19.
60. Macdougall, I.C., Bock, A.H., Carrera, F., Eckardt, K.U., Gaillard, C., Van Wyck, D., Roubert, B., Nolen, J.G. & Roger, S.D. (2014) FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 29, 2075–2084.
61. Mancias, J.D., Wang, X., Gygi, S.P., Harper, J.W. & Kimmelman, A.C. (2014) Quantitative proteomics identifies NCOA4 as the cargo receptor mediating ferritinophagy. Nature, 509, 105–109.
62. Mancias, J.D., Pontano Vaites, L., Nissim, S., Biancur, D.E., Kim, A.J., Wang, X., Liu, Y., Goessling, W., Kimmelman, A.C. & Harper, J.W. (2015). Ferritinophagy via NCOA4 is required for erythropoiesis and is regulated by iron dependent HERC2-mediated proteolysis. eLife 4, e10308.
63. Mastrogiannaki, M., Matak, P. & Peyssonnaux, C. (2013) The gut in iron homeostasis: role of HIF-2 under normal and pathological conditions. Blood, 122, 885–892.
64. Matak, P., Matak, A., Moustafa, S., Aryal, D.K., Benner, E.J., Wetsel, W. & Andrews, N.C. (2016) Disrupted iron homeostasis causes dopaminergic neurodegeneration in mice. Proceedings of the National Academy of Sciences of the United States of America, 113, 3428–3435.
65. Mleczko-Sanecka, K., Roche, F., da Silva, A.R., Call, D., D'Alessio, F., Ragab, A., Lapinski, P.E., Ummanni, R., Korf, U., Oakes, C., Damm, G., D'Alessandro, L.A., Klingmuller, U., King, P.D., Boutros, M., Hentze, M.W. & Muckenthaler, M.U. (2014) Unbiased RNAi screen for hepcidin regulators links hepcidin suppression to proliferative Ras/RAF and nutrient-dependent mTOR signaling. Blood, 123, 1574–1585.
66. Mleczko-Sanecka, K., da Silva, A.R., Call, D., Neves, J., Schmeer, N., Damm, G., Seehofer, D. & Muckenthaler, M.U. (2017) Imatinib and spironolactone suppress hepcidin expression. Haematologica, 102, 1173–1184.
67. Moretti, D., Goede, J.S., Zeder, C., Jiskra, M., Chatzinakou, V., Tjalsma, H., Melse-Boonstra, A., Brittenham, G., Swinkels, D.W. & Zimmermann, M.B. (2015) Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women. Blood, 126, 1981–1989.
68. Nai, A., Pagani, A., Mandelli, G., Lidonnici, M.R., Silvestri, L., Ferrari, G. & Camaschell, C. (2012) Deletion of TMPRSS6 attenuates the phenotype in a mouse model of beta-thalassemia. Blood, 119, 5021–5029.
69. Nai, A., Pellegrino, R.M., Rausa, M., Pagani, A., Boero, M., Silvestri, L., Saglio, G., Roetto, A. & Camaschella, C. (2014) The erythroid function of transferrin receptor 2 revealed by Tmprss6 inactivation in different models of transferrin receptor 2 knockout mice. Haematologica, 99, 1016–1021.
70. Nai, A., Lidonnici, M.R., Rausa, M., Mandelli, G., Pagani, A., Silvestri, L., Ferrari, G. & Camaschella, C. (2015) The second transferrin receptor regulates red blood cell production in mice. Blood, 125, 1170–1179.
71. Nai, A., Rubio, A., Campanella, A., Gourbeyre, O., Artuso, I., Bordini, J., Gineste, A., Latour, C., Besson-Fournier, C., Lin, H.Y., Coppin, H., Roth, M.P., Camaschella, C., Silvestri, L. & Meynard, D. (2016) Limiting hepatic Bmp-Smad signaling by matriptase-2 is required for erythropoietin-mediated hepcidin suppression in mice. Blood, 127, 2327–2336.
72. Nai, A., Lidonnici, M.R., Artuso, I., Federico, G., Mandelli, G., Ferrari, G., Camaschella, C., Carlomagno, F. & Silvestri, L. (2017) The macrophage nuclear receptor coactivator 4 counteracts iron-deficiency anemia. Blood, 130, 224.
73. Nemeth, E., Tuttle, M.S., Powelson, J., Vaughn, M.B., Donovan, A., Ward, D.M., Ganz, T. & Kaplan, J. (2004) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science, 306, 2090–2093.
74. Pasricha, S.R., Atkinson, S.H., Armitage, A.E., Khandwala, S., Veenemans, J., Cox, S.E., Eddowes, L.A., Hayes, T., Doherty, C.P., Demir, A.Y., Tijhaar, E., Verhoef, H., Prentice, A.M. & Drakesmith, H. (2014) Expression of the iron hormone hepcidin distinguishes different types of anemia in African children. Science Translational Medicine, 6, 235re3.
75. Pasricha, S.R., Lim, P.J., Duarte, T.L., Casu, C., Oosterhuis, D., Mleczko-Sanecka, K., Suciu, M., Da Silva, A.R., Al-Hourani, K., Arezes, J., McHugh, K., Gooding, S., Frost, J.N., Wray, K., Santos, A., Porto, G., Repapi, E., Gray, N., Draper, S.J., Ashley, N., Soilleux, E., Olinga, P., Muckenthaler, M.U., Hughes, J.R., Rivella, S., Milne, T.A., Armitage, A.E. & Drakesmith, H. (2017) Hepcidin is regulated by promoter-associated histone acetylation and HDAC3. Nature Communications, 8, 403.
76. Ponikowski, P., van Veldhuisen, D.J., Comin-Colet, J., Ertl, G., Komajda, M., Mareev, V., McDonagh, T., Parkhomenko, A., Tavazzi, L., Levesque, V., Mori, C., Roubert, B., Filippatos, G., Ruschitzka, F. & Anker, S.D. (2015) Beneficial effects of long-term intravenous iron therapy with ferric carboxymaltose in patients with symptomatic heart failure and iron deficiency. European Heart Journal, 36, 657–668.
77. Prentice, A.M., Doherty, C.P., Abrams, S.A., Cox, S.E., Atkinson, S.H., Verhoef, H., Armitage, A.E. & Drakesmith, H. (2012) Hepcidin is the major predictor of erythrocyte iron incorporation in anemic African children. Blood, 119, 1922–1928.
78. Ramos, E., Kautz, L., Rodriguez, R., Hansen, M., Gabayan, V., Ginzburg, Y., Roth, M.P., Nemeth, E. & Ganz, T. (2011) Evidence for distinct pathways of hepcidin regulation by acute and chronic iron loading in mice. Hepatology, 53, 1333–1341.
79. Rausa, M., Pagani, A., Nai, A., Campanella, A., Gilberti, M.E., Apostoli, P., Camaschella, C. & Silvestri, L. (2015) Bmp6 expression in murine liver non parenchymal cells: a mechanism to control their high iron exporter activity and protect hepatocytes from iron overload? PLoS ONE, 10, e0122696.
80. Ryu, M.S., Zhang, D., Protchenko, O., Shakoury-Elizeh, M. & Philpott, C.C. (2017) PCBP1 and NCOA4 regulate erythroid iron storage and heme biosynthesis. The Journal of Clinical Investigation, 127, 1786–1797.
81. van Santen, S., de Mast, Q., Oosting, J.D., van Ede, A., Swinkels, D.W. & van der Ven, A.J. (2014) Hematologic parameters predicting a response to oral iron therapy in chronic inflammation. Haematologica, 99, e171–e173.
82. Schmidt, P.J., Toudjarska, I., Sendamarai, A.K., Racie, T., Milstein, S., Bettencourt, B.R., Hettinger, J., Bumcrot, D. & Fleming, M.D. (2013) An RNAi therapeutic targeting Tmprss6 decreases iron overload in Hfe(-/-) mice and ameliorates anemia and iron overload in murine beta-thalassemia intermedia. Blood, 121, 1200–1208.
83. Seldin, M.M., Peterson, J.M., Byerly, M.S., Wei, Z. & Wong, G.W. (2012) Myonectin (CTRP15), a novel myokine that links skeletal muscle to systemic lipid homeostasis. The Journal of Biological Chemistry, 287, 11968–11980.
84. Silvestri, L., Pagani, A., Nai, A., De Domenico, I., Kaplan, J. & Camaschella, C. (2008) The serine protease matriptase-2 (TMPRSS6) inhibits hepcidin activation by cleaving membrane hemojuvelin. Cell Metabolism, 8, 502–511.
85. Sonnweber, T., Nachbaur, D., Schroll, A., Nairz, M., Seifert, M., Demetz, E., Haschka, D., Mitterstiller, A.M., Kleinsasser, A., Burtscher, M., Trubsbach, S., Murphy, A.T., Wroblewski, V., Witcher, D.R., Mleczko-Sanecka, K., Vecchi, C., Muckenthaler, M.U., Pietrangelo, A., Theurl, I. & Weiss, G. (2014) Hypoxia induced downregulation of hepcidin is mediated by platelet derived growth factor BB. Gut, 63, 1951–1959.
86. Steinbicker, A.U., Bartnikas, T.B., Lohmeyer, L.K., Leyton, P., Mayeur, C., Kao, S.M., Pappas, A.E., Peterson, R.T., Bloch, D.B., Yu, P.B., Fleming, M.D. & Bloch, K.D. (2011) Perturbation of hepcidin expression by BMP type I receptor deletion induces iron overload in mice. Blood, 118, 4224–4230.
87. Stoffel, N.U., Cercamondi, C.I., Brittenham, G., Zeder, C., Geurts-Moespot, A.J., Swinkels, D.W., Moretti, D. & Zimmermann, M.B. (2017) Iron absorption from oral iron supplements given on consecutive versus alternate days and as single morning doses versus twice-daily split dosing in iron-depleted women: two open-label, randomised controlled trials. The Lancet. Haematology, 4, e524–e533.
88. Theurl, I., Hilgendorf, I., Nairz, M., Tymoszuk, P., Haschka, D., Asshoff, M., He, S., Gerhardt, L.M., Holderried, T.A., Seifert, M., Sopper, S., Fenn, A.M., Anzai, A., Rattik, S., McAlpine, C., Theurl, M., Wieghofer, P., Iwamoto, Y., Weber, G.F., Harder, N.K., Chousterman, B.G., Arvedson, T.L., McKee, M., Wang, F., Lutz, O.M., Rezoagli, E., Babitt, J.L., Berra, L., Prinz, M., Nahrendorf, M., Weiss, G., Weissleder, R., Lin, H.Y. & Swirski, F.K. (2016) On-demand erythrocyte disposal and iron recycling requires transient macrophages in the liver. Nature Medicine, 22, 945–951.
89. Traglia, M., Girelli, D., Biino, G., Campostrini, N., Corbella, M., Sala, C., Masciullo, C., Vigano, F., Buetti, I., Pistis, G., Cocca, M., Camaschella, C. & Toniolo, D. (2011) Association of HFE and TMPRSS6 genetic variants with iron and erythrocyte parameters is only in part dependent on serum hepcidin concentrations. Journal of Medical Genetics, 48, 629–634.
90. Troutt, J.S., Rudling, M., Persson, L., Stahle, L., Angelin, B., Butterfield, A.M., Schade, A.E., Cao, G. & Konrad, R.J. (2012) Circulating human hepcidin-25 concentrations display a diurnal rhythm, increase with prolonged fasting, and are reduced by growth hormone administration. Clinical Chemistry, 58, 1225–1232.
91. Wahedi, M., Wortham, A.M., Kleven, M.D., Zhao, N., Jue, S., Enns, C.A. & Zhang, A.S. (2017) Matriptase-2 suppresses hepcidin expression by cleaving multiple components of the hepcidin induction pathway. The Journal of Biological Chemistry, 292, 18354–18371.
92. Wang, R.H., Li, C., Xu, X., Zheng, Y., Xiao, C., Zerfas, P., Cooperman, S., Eckhaus, M., Rouault, T., Mishra, L. & Deng, C.X. (2005) A role of SMAD4 in iron metabolism through the positive regulation of hepcidin expression. Cell Metabolism, 2, 399–409.
93. Wang, H., An, P., Xie, E., Wu, Q., Fang, X., Gao, H., Zhang, Z., Li, Y., Wang, X., Zhang, J., Li, G., Yang, L., Liu, W., Min, J. & Wang, F. (2017) Characterization of ferroptosis in murine models of hemochromatosis. Hepatology, 66, 449–465.
94. Weiss, G. & Goodnough, L.T. (2005) Anemia of chronic disease. The New England Journal of Medicine, 352, 1011–1023.
95. Xu, W., Barrientos, T., Mao, L., Rockman, H.A., Sauve, A.A. & Andrews, N.C. (2015) Lethal cardiomyopathy in mice lacking transferrin receptor in the heart. Cell Reports, 13, 533–545.
96. Yanatori, I., Richardson, D.R., Toyokuni, S. & Kishi, F. (2017) The iron chaperone poly(rC)-binding protein 2 forms a metabolon with the heme oxygenase 1/cytochrome P450 reductase complex for heme catabolism and iron transfer. The Journal of Biological Chemistry, 292, 13205–13229.
97. Yang, X., Park, S.H., Chang, H.C., Shapiro, J.S., Vassilopoulos, A., Sawicki, K.T., Chen, C., Shang, M., Burridge, P.W., Epting, C.L., Wilsbacher, L.D., Jenkitkasemwong, S., Knutson, M., Gius, D. & Ardehali, H. (2017) Sirtuin 2 regulates cellular iron homeostasis via deacetylation of transcription factor NRF2. The Journal of Clinical Investigation, 127, 1505–1516.
98. Yu, H., Guo, P., Xie, X., Wang, Y. & Chen, G. (2017) Ferroptosis, a new form of cell death, and its relationships with tumourous diseases. Journal of Cellular and Molecular Medicine, 21, 648–657.
99. Zhao, N., Nizzi, C.P., Anderson, S.A., Wang, J., Ueno, A., Tsukamoto, H., Eisenstein, R.S., Enns, C.A. & Zhang, A.S. (2015) Low intracellular iron increases the stability of matriptase-2. The Journal of Biological Chemistry, 290, 4432–4446.